Chondrocytes produce many types of ECM to maintain elasticity and plasticity in articular cartilage of revolute joints. Both transforming growth factor ß (TGF-ß) and bone morphogenetic proteins (BMPs) induce extracellular matrix proteins such as type II·1 collagen and aggrecan during chondrogenic differentiation in vitro. However, differences in the matrix gene expression pattern by the stimulation of TGF-ßs and BMPs remains unclear. In the present study, we created a customized PCR-based ECM array to investigate the pattern of ECM expression genes in the chondrocyte progenitor cell line ATDC5, that was stimulated by TGF-ßs or BMPs. Fibronectin (Fn) expression was drastically induced after TGF-ß stimulation, but not BMP-4. Epidermal growth factor receptor (Egfr) gene was also significantly activated in TGF-ß1-induced chondrogenic differentiation as compared to BMP-4-mediated differentiation. Furthermore, EGFRknockdown assay of the cells showed decreasing Fn expression during TGF-ß1-induced chondrogenic differentiation. These data indicated that Egfr gene activation by TGF-ß is involved in the differences in the expression of cellular matrix genes such as Fn, as compared to the expression pattern induced by BMPs.
Introduction
Cartilage absorbs shock and provides a smooth articulating surface for proper joint mobility. Articular cartilage is comprised of chondrocytes and their surrounding hydrated proteoglycans such as aggrecan and collagen. Chondrocytes maintain cartilage homeostasis through a balance of the extracellular matrice (ECM) synthesis and the degradation, although they occupy <5% of the total tissue volume (1) .
Previous studies have shown that several growth factors are implicated in chondrogenesis, such as fibroblast growth factors (2, 3) , insulin-like growth factor (4-6), TGF-ß (7-9), and bone morphogenetic proteins (BMP) (3, 10, 11) . The TGF-ß family, in particular, is strongly associated with chondrogenic differentiation.
TGF-ßs signal through heteromeric TGF-ßs receptors composed of type I and type II serine/threonine kinases. The receptor associated Smads, Smad2 and 3, was phosphorylated by activated type I receptors after heteromeric receptor complex formation. The phosphorylated Smads associates with Smad4, translocate to the nucleus, and act as transcription factors. In contrast, BMPs transduce the signal via type I and type II BMP receptors complex. Then, Smad1, 5, and 8, the BMPs signal-associated Smads, are phosphorylated by the activated type I BMP receptor, and regulate gene expression with Smad4 (12) . The TGF-ßs also appear to signal through the MAPK pathway via the MAPKKK, TAK1 (TGF-ß activated kinase), and its associated partner TAB1 (TAK1 binding protein) (13, 14) .
TGF-ß is a multifunctional cytokine that is crucially involved in multiple processes throughout development, ECM synthesis, cell proliferation, differentiation, and tissue repair. Baker et al reported that, in cartilage, TGF-ß1 promotes cartilage matrix synthesis and induces the activity of tissue inhibitor of metalloproteinase-3 (TIMP-3), which inhibits matrix metalloproteinases, aggrecanases, and TNF-ßconverting enzyme, all of which are implicated in articular cartilage degradation and joint inflammation (15) . In contrast, BMPs and their receptors are required for chondrogenesis and are expressed throughout the growth plate and perichondrium (16, 17) . BMPs, but not TGF-ß promote differentiation at a late stage, which are required for the induction of type X Activation of epidermal growth factor receptor gene is involved in transforming growth factor-ß-mediated fibronectin expression in a chondrocyte progenitor cell line collagen, and leads to ossification (18, 19) . Though TGF-ßs and BMPs have different characteristics, they both induce major cartilage matrix synthesis such as aggrecan and type II·1 collagen through different pathways, and they are both important for chondrogenic regulation.
In the present study, we demonstrated that TGF-ß, but not BMP-4, induces Fibronectin (Fn) expression during the chondrogenic differentiation of ATDC5 cells. Furthermore, expression of the EGFR ligands, Tgf-· and Hb-egf, and Egf receptor (Egfr/ErbB1) significantly increased during the TGF-ß-induced chondrogenic differentiation. The induction of Fn gene by TGF-ß stimulation was disturbed during chondrogenic differentiation in the EGFR-knocked-down ATDC5 cells. These data indicated that the EGFR signaling cascade is associated with FN synthesis during TGF-ß-induced chondrogenic differentiation.
Materials and methods
Cell cultures. ATDC5 (RIKEN cell bank; Tsukuba, Japan) was purchased from the RIKEN cell bank. ATDC5 cells were maintained in a 1:1 mixture of DME and Ham's F-12 (DME/F12) medium (Wako, Osaka, Japan) containing 5% FBS (Nichirei Bioscience, Tokyo, Japan) and TS, which consisted of 10 μg/ml human transferrin (T; Roche Diagnostics, Mannheim, Germany), and 3x10 -8 M sodium selenite (S; Sigma, St. Louis, MO, USA), as previously described (11, 20, 21) . The medium was replaced every other day. In some experiments, ATDC5 cells were plated at a density of 6x10 4 cells per 35-mm dish and cultured in DME/F12 medium containing 5% FBS and TS. On day 3 after the cells were plated, the culture medium was replaced by DME/F12 medium containing 5% FBS, TS, and either 10 μg/ml human insulin (I; Roche Diagnostics) or human recombinant BMP-4 (R&D Systems, Minneapolis, MN, USA) or human recombinant TGF-ß1 (R&D Systems). The medium and the ligands were replaced every other day.
Western blotting. The experiments were terminated by aspirating the culture medium and washing the cells three times with ice-cold PBS. Cell lysates were prepared in 0.5 M Tris lysis buffer (pH 6.8) containing 2% sodium dodecyl sulfate, 2-mercaptoethanol, and 5% glycerol and then subjected to sonication. They were stored at -80˚C until use. For Western blot analysis, equal amounts of proteins were pooled from triplicate samples and separated by 6% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). Following SDS-PAGE, proteins were transferred to nitrocellulose membranes. Immunoblots were blocked with 5% milk in Tris-buffered saline with 0.1% Tween-20 and then probed overnight with primary antibodies (1:1000 dilution). Western blotting was performed by using rabbit monoclonal antibodies against EGFR (Cell Signaling Technology, Danvers, MA, USA) and mouse monoclonal antibodies against ß-actin (Sigma), followed by incubation with anti-rabbit IgG or antimouse IgG. The results were visualized by using the ECL Plus detection kit (Pharmacia) and quantified with Gel-Pro Analyzer software (Media Cybernetics, Silver Spring, MD, USA). Where indicated, the blots were stripped according to the ECL Plus protocol prior to re-probing.
Quantitative reverse-transcription polymerase chain reaction (qRT-PCR). Total RNA was extracted from cells by using TRIzol reagent (Invitrogen, La Jolla, CA, USA), and firststrand cDNA was synthesized from 1 μg of RNA by using Superscript III (Invitrogen). The Applied Biosystems 7300 real-time PCR system (Applied Biosystems, Foster City, CA, USA) was used to perform quantitative real-time RT-PCR was performed in a 25-μl reaction volume containing 15 μl of the SYBR Green qPCR Supermix Universal (Invitrogen), 1 μl of the RT reaction mixture, and 200 nM primers. The primer sequences are listed in Table I . All primers generated PCR fragments with the correct sizes, and non-specific products were not generated; thus, the specificity of the realtime RT-PCR was confirmed (data not shown). The cycle threshold (Ct) value for each gene of interest was measured for each RT sample.
Lentiviral shRNA-mediated knockdown of EGFR in ATDC5 cells. To produce ATDC5 cells in which the expression of the
Egfr gene is suppressed during long-term culture, a lentivirusmediated RNA interference-knockdown system was applied Table I . Primer used for qRT-PCR.
to the ATDC5 cells. An HIV-based self-inactivating lentiviral expression vector (CSII-CMV-MCS-IRES-Bsd) and two packaging vectors (pCAG-HIVgp and pCMV-VSV-G-RSV-Rev) were obtained from Dr Hiroyuki Miyoshi (RIKEN BioResource Center, Japan) (22) . A human H1-RNA pol III promoter (-217 to +1) DNA fragment was amplified by polymerase chain reaction. To drive the expression of a small hairpin RNA shRNA, the H1 promoter was into the U3 region of the 3'-long terminal repeat (LTR) in the original lentiviral vector, as described previously (23), in order to drive the expression of a small hairpin RNA (shRNA). In the modified shRNA expression vector, termed CSII-CMV-IRES-Bsd-H1, BamHI and EcoRI sites were introduced into the 3' end of the H1 promoter, allowing the insertion of the shRNA template. The original algorithm (B-Algo™) from B-Bridge International (Tokyo, Japan) was used to design specific shRNA target sequences. The target sequence of the mouse Egfr gene for knockdown was 5'-GGGAAATGCT CTTTATGAA-3', corresponding to the 324-342 nucleotide positions of the mouse Egfr coding sequence (GenBank accession no. NM_207655). The targeting sequence for EGFP-shRNA, (5'-CTACAACAGCCACAACGTC-3') was selected as a negative control. To construct the shRNA expression cassette, two complementary oligonucleotides were synthesized, annealed, and inserted between the BamHI and EcoRI sites just downstream of the H1 promoter. The shRNA cassette features a TTCAAGAGA loop situated between the sense and reverse complementary targeting sequences and a TTTTT terminator at the 3'-end as described previously (24) . The lentiviral vector also carries a blasticidinresistant gene as a transduction selection marker. Lentiviral particles were generated by using a standard transfection procedure. After transduction of the transgenes, a pool of blastidin-resistant ATDC5 was used to analyze the gene expression downstream of the EGFR-dependent signal during chondrogenic differentiation.
RT 2 Profiler Customized PCR array system. The expression levels of 42 chondrogenic-related mouse genes were examined by using the customized RT 2 Profiler PCR array (SuperArray Bioscience, Frederick, MD, USA). The TRIzol reagent (Invitrogen) and Superscript III (Invitrogen) were used to isolate total RNA from the wild-type ATDC5 cells and ATDC5 cells that were infected with shRNA lentivirus vector against Gfp (shGfp/ATDC5) or Egfr (shEgfr/ATDC5). cDNA was synthesized from 1 μg of RNA by using a SuperScript RT II enzyme (Invitrogen). The Applied Biosystems 7300 real-time PCR system and RT 2 Profiler PCR array system were used to perform PCR, according to the manufacturer's instructions. The mRNA expression level of each gene in shEgfr/ATDC5 was normalized against the housekeeping gene expression (Gusb, Hprt1, Hspcb, Gapdh, and Actb), and then compared with the data obtained from shGfp/ATDC5. Individual RNA samples from the cells in each group were subjected to quantitative RT-PCR to confirm the results. The primers used for the RT 2 Profiler Customized PCR array are listed in Table II .
Statistical analysis. The results are presented as mean ± SE. The two groups were compared by using the Student's t-test.
Analysis of variance with Bonferroni's post-hoc test was used for multiple comparisons. Statistical significance was established at p<0.05.
Results
Chondrocyte-related ECM gene expression after treatment with TGF-ß1 and BMP-4. We analyzed the gene expression Table II . Primers used for RT 2 profiler customized PCR array system.
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profiles of chondrocyte-related ECM genes during chondrogenic differentiation of ATDC5 cells treated with TGF-ß1 or BMP-4. We performed qRT-PCR to analyze the mRNA expression levels of the chondrogenic-related genes, and we assessed the expression of chondrocyte-related ECM genes by using an RT 2 Profiler PCR array system customized for profiling ECM genes. We compared the expression levels of genes in 3-day-differentiated cells treated with TGF-ß1 or BMP-4. Fibronectin (Fn) was greatly up-regulated in TGF-ß1-treated cells, as compared to untreated cells or BMP-4treated cells (Fig. 1A) . The significantly higher expression levels of Fn in TGF-ß1-treated cells was confirmed by qRT-PCR with another specific primer set for the Fn gene (Fig. 1B) . TGF-ß1-treated ATDC5 cells adopted, a spindle-shaped phenotype, while BMP-4-treated cells displayed a round phenotype on day 3 after differentiation (Fig. 1C ).
TGF-ß1, but not BMP-4, strongly up-regulates the gene expression of EGFR in ATDC5 cells.
In mesangial cells from the kidney, TGF-ß treatment stimulates the processing and release of HB-EGF which in turn transactivates the EGFRmediated ERK and p38 MAPK cascades that regulate Fn gene transcription (25) . Therefore, we examined whether or not the expression of the ErbB gene family, including Egfr, is dependent on TGF-ß1 or BMP-4 signal during chondrogenic differentiation. We performed qRT-PCR to analyze the mRNA expression levels of Egfr, and ErbB2, ErbB3 and ErbB4 in ATDC5 cells treated with TGF-ß1 or BMP-4. TGF-ß, but not BMP-4, strongly up-regulated the gene expression of Egfr ( Fig. 2A) . The up-regulation of ErbB2 and B3 was significantly less than the up-regulation of Egfr in TGF-ß1-treated cells. ErbB4 was not detected after stimulation by either ligand (data not shown).
To determine if the activation of the Egfr gene is dependent on the concentration of TGF-ß1, ATDC5 cells were stimulated with four different concentrations of TGF-ß1 (0, 0.1, 1, and 10 ng/ml) for 3 days. We found that Egfr, along with the major chondrocyte-specific ECM genes such as CollagenII·1 (ColII·1) and aggrecan (Acan), was up-regulated in a TGF-ß1 dose-dependent manner (Fig. 2B) . Western blot analysis showed that the EGFR protein level was also induced by TGF-ß1 (Fig. 2C) . We also analyzed the expression of EGFR ligands, TGF-· and Hb-egf, after treatment with TGF-ß1 and BMP-4 during chondrogenic differentiation. TGF-· and Hb-egf were more strongly expressed during induction with TGF-ß1 than with BMP-4 ( Fig. 2D) . Thus, these findings indicate that TGF-ß1-induced chondrogenic cells could activate their own EGFR signaling cascade by the autocrine secretion of TGF-· and HB-EGF.
A knockdown assay by shRNA against Egfr. To investigate whether EGFR affects chondrogenic differentiation with TGF-ß1 treatment, we performed an Egfr knockdown assay with lentivirus vectors carrying two shRNAs targeting Egfr (lenti-shEgfr) or green fluorescent protein (lenti-shGfpy), which was used as a control. We infected ATDC5 cells with each of lenti-shRNA and assessed the Egfr suppression by RT-PCR and Western blotting. Egfr gene expression in ATDC5 cells was more effectively down-regulated by infection with lenti-shEgfr than by infection with lenti-shGfp (Fig. 3A) . In contrast, the gene expression levels of ErbB2 and ErbB3 were not down-regulated in shEgfr/ATDC5 (Fig. 3B) . Western blotting revealed that the protein level of EGFR was significantly decreased in shEgfr/ATDC5 (Fig. 3C ).
EGFR knockdown leads to the down-regulation of Fn during chondrogenic differentiation induced by TGF-ß1 treatment.
We used the RT 2 Profiler Customized PCR array system to examine the effect of EGFR knockdown on the expression of ECM and matrix metalloprotease genes in TGF-ß1-treated parental ATDC5 cells, shEgfr/ATDC5 or shGfp/ATDC5. shEgfr/ATDC5 had a lower expression of four ECM genes, CollagenX·1 (ColX·1), CollagenXVII·1 (ColXVII·1), Acan, and Fn, in ECM genes as compared to parental ATDC5 cells and shGfp/ATDC5 (Fig. 4A) . The expression level of Fn was significantly lower in shEgfr/ATDC5 than in shGfp/ATDC5 in a time-dependent manner with TGF-ß1 treatment (Fig. 4B) . These data suggest that the TGF-ß signaling could regulate certain ECM genes, such as FN via EGFR signaling during chondrogenesis.
Discussion
In our study, we focused on the differences in the pattern of ECM genes induced by TGF-ß1 and BMP-4. The customized RT-PCR array analysis showed that there was a definite difference in Fn gene expression. FN is a large dimeric glycoprotein that functions primarily as a connecting molecule in the ECM by both cell-matrix and matrix-matrix interactions. FN is involved in cell adhesion, migration, and ECM accumulation in processes such as embryogenesis, wound healing, blood coagulation, host defense, and metastasis. Various isoforms are produced from a single FN gene, and full length recombinant FN reduces spreading and promotes the condensation and chondrogenesis of limb mesenchymal cells (26) . FN expression is increased in areas of cellular condensation that are decreased as cytodifferentiation proceeds (27, 28) . According to recent studies, isoform switching of Fn mRNA is important for chondrogenic differentiation (29) (30) (31) and that TGF-ß1 treatment during chondrogenic differentiation of ATDC5 cells increases the expression of FN isoforms that lack the extra domainA and B during chondrogenic differentiation of ATDC5 cells (32, 33) . Regulation of both quantity and quality of FN by TGF-ß1 could be involved in the early stage of chondrogenesis.
It was previously reported that HB-EGF and EGFR transactivation are involved in TGF-ß-mediated FN expression in mesangial cells, however, the new protein synthesis induced by TGF-ß did not participate in induction of FN expression (25) . In contrast, our study found that EGFR expression in ATDC5 cells is induced by TGF-ß treatment and that this expression is crucial for Fn gene expression. We believe that differences in the cell types are responsible for the different results of these two studies. The study that Fn mRNA is stabilized by TGF-ß-dependent protein synthesis in cardiac fibroblasts supports this speculation (34) .
Our study also showed that the knockdown of EGFR expression in the chondrogenic ATDC5 cells reduces the expression levels of several ECM genes such as ColX·1, ColXVII·1, and Acan as well as Fn (Fig. 4A ). It has been even reported that expression of TGF-·, a member of the EGFR ligand family, in mouse lungs caused extensive pulmonary fibrosis without inflammation (35) . A recent study indicated that EGF receptor tyrosine kinase inhibitors diminish TGF-ß-induced pulmonary fibrosis (36) . Amphiregulin, another member of the EGFR ligand family, is involved in Figure 3 . A knockdown assay by shRNA against Egfr. A knockdown assay of Egfr mRNA is performed to see the function of EGFR during chondrogenesis. (A) Gene expression of Egfr was compared between shEgfr/ ATDC5 and shGfp/ATDC5 using qRT-PCR. The results are normalized to Hprt1 and presented as a fold change relative to the expression of day 0. The expression of Egfr in a comparison between shEgfr/ATDC5 and shGfp/ ATDC5 on day 3 of TGF-ß1-induced differentiation. (B) Gene expression levels of Erbb2 and 3 were compared between shEgfr/ATDC5 and shGfp/ ATDC5. (C) Western blots of ATDC5 were probed for EGFR. Antibodies against ß-actin were used as a loading control. n.t., no treatment. the development of mouse liver fibrosis (37) . Other studies showed that TGF-·, HB-EGF, or EGFR plays a critical part in pancreatic fibrosis formation (38) (39) (40) . These findings suggest that EGFR signaling is important in extracellular matrix production as with cell growth and survival.
In conclusion, the expression of EGFR and its ligands is required for the TGF-ß-mediated expression of ECM genes such as Fn during the chondrogenic differentiation of ATDC5 cells. BMP-4, which induces late-stage chondrocyte differentiation, did not induce the Egfr gene products that regulate ECM genes. We concluded that EGFR signaling in chondrocytes might prevent mineralization and subsequent ossification such that chondrocytes continue to produce articular cartilage-specific ECM. 
